Laber Damian A
Division of Hematology and Medical Oncology, University of Louisville, J.G. Brown Cancer Center, Louisville, KY 40202, USA.
Med Oncol. 2006;23(4):443-54. doi: 10.1385/MO:23:4:443.
Knowledge about renal cell carcinoma (RCC) has increased exponentially over the last decades. A clear understanding of RCC is of utmost importance to prevent the disease and improve the outcomes. Large epidemiologic studies have identified cigarette smoking, chemical agents, obesity, hypertension, and end-stage renal disease as risk factors associated with RCC. Identification and confirmation of risk factors may be projected into preventive strategies. Genetic studies of inherited disorders associated with an enhanced risk of RCC have elucidated many important targets for anticancer therapy. The World Health Organization (WHO) has recently developed a new histologic classification of renal cell tumors that has demonstrated prognostic utility. A refined clinical staging system is improving our ability to prognosticate the outcome of RCC patients. This article provides a practical yet comprehensive review of the risk factors, classification, and staging of RCC focusing on recent updates.
在过去几十年里,关于肾细胞癌(RCC)的知识呈指数级增长。对肾细胞癌有清晰的了解对于预防该疾病和改善治疗结果至关重要。大型流行病学研究已确定吸烟、化学制剂、肥胖、高血压和终末期肾病为与肾细胞癌相关的风险因素。风险因素的识别与确认可纳入预防策略。对与肾细胞癌风险增加相关的遗传性疾病的基因研究已阐明了许多重要的抗癌治疗靶点。世界卫生组织(WHO)最近制定了一种新的肾细胞肿瘤组织学分类,已证明其具有预后价值。一种完善的临床分期系统正在提高我们对肾细胞癌患者预后进行预测的能力。本文对肾细胞癌的风险因素、分类和分期进行了实用而全面的综述,重点关注近期的更新内容。